Press Releases :: BiomX, Inc. (PHGE)

Sep 07, 2023 9:00am EDT

BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023

Sep 06, 2023 4:05pm EDT

BiomX to Present at H.C. Wainwright 25th Annual Global Investment Conference

Aug 09, 2023 6:30am EDT

BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 02, 2023 4:30pm EDT

BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023

Jun 08, 2023 5:00pm EDT

NYSE American Initiates Delisting Proceedings for BiomX Warrants

May 31, 2023 3:00am EDT

BiomX to Present Part 1 Data from Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis During Late-Breaking Science Session at the 46th European Cystic Fibrosis Conference (ECFC)

May 15, 2023 6:30am EDT

BiomX Reports First Quarter 2023 Financial Results and Provides Business Update

May 12, 2023 8:00am EDT

BiomX Announces the Appointments of Jason M. Marks and Michael E. Dambach to Board of Directors

May 08, 2023 6:30am EDT

BiomX to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 15th, 2023

May 05, 2023 6:30am EDT

BiomX Announces Second Closing of $7.5 Million Private Placement

Previous
1
2
3
4
5
6
7
8
9
10
…13
Next

Investor Contact Information

Company

BiomX, Inc.
708 Quince Orchard Rd
Suite 205
Gaithersburg, MD 20878
USA
info@biomx.com

Investor Relations

Ben Cohen
benc@biomx.com